Sol-Gel Technologies SLGL
NASDAQ SLGL
$69.96 -0.14 (-0.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sol-Gel Technologies (SLGL) Enterprise Value (2018 - 2026)

Sol-Gel Technologies (SLGL) posted quarterly Enterprise Value of -$10.1 million for Q1 2026, up 39.99% year-over-year from -$7.2 million in Q1 2025, and up 57.76% quarter-over-quarter from -$24.0 million in Q4 2025.

Analysis

Sol-Gel Technologies (SLGL) Enterprise Value (2018 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has reported Enterprise Value for 11 consecutive years, with -$10.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Enterprise Value rose 39.99% year-over-year to -$10.1 million; the TTM figure through Mar 2026 stood at -$10.1 million (up 39.99% YoY), while the FY2025 annual figure was -$24.0 million, up 4.35% from the prior year.
  • Enterprise Value improved to -$10.1 million in Q1 2026 per SLGL's latest filing, from -$24.0 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$6.7 million in Q3 2025 and bottomed at -$42.2 million in Q2 2022.
  • Historically, Enterprise Value has averaged -$20.3 million across 5 years, with a median of -$21.1 million in 2022.
  • On a YoY basis, Enterprise Value climbed as much as 80.39% in 2022 and fell as far as 68.07% in 2022.
  • Sol-Gel Technologies' Enterprise Value stood at -$21.1 million in 2022, then slumped by 32.46% to -$28.0 million in 2023, then grew by 14.54% to -$23.9 million in 2024, then retreated by 0.36% to -$24.0 million in 2025, then surged by 57.76% to -$10.1 million in 2026.
  • Business Quant data shows SLGL's Enterprise Value at -$10.1 million in Q1 2026, -$24.0 million in Q4 2025, and -$6.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Sol-Gel Technologies 194.01 Mn 146.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 158.64 Mn
Mar 31, 2026 167.89 Mn
Dec 31, 2025 93.41 Mn
Sep 30, 2025 74.49 Mn
Jun 30, 2025 -62,360.93
Mar 31, 2025 -2.42 Mn
Dec 31, 2024 1.99 Mn
Sep 30, 2024 -9.11 Mn
Jun 30, 2024 -2.83 Mn
Mar 31, 2024 11.08 Mn
Dec 31, 2023 2.80 Mn
Sep 30, 2023 11.57 Mn
Jun 30, 2023 38.87 Mn
Mar 31, 2023 74.44 Mn
Dec 31, 2022 84.34 Mn
Sep 30, 2022 90.60 Mn
Jun 30, 2022 52.58 Mn
Mar 31, 2022 140.42 Mn
Dec 31, 2021 149.34 Mn
Sep 30, 2021 184.42 Mn